ArticleBritish journal of cancer2023

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.

Helena J Janse van Rensburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.